Biwei Yang
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
- MicroRNA in disease regulation
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 9
- Co-authors
- Jinglin Xia (28 shared papers)Wenqing Tang (11 shared papers)Si Zhang (4 shared papers)Peixin Huang (11 shared papers)Tingting Fang (7 shared papers)Meiyi Li (1 shared paper)Weixin Liu (1 shared paper)Luonan Chen (1 shared paper)
- Journals
- Journal of Translational Medicine (3 papers)Experimental Cell Research (2 papers)Journal of Experimental & Clinical Cancer Research (2 papers)Cellular Physiology and Biochemistry (2 papers)Journal of Ethnopharmacology (2 papers)
- Partner nations
- ChinaEthiopiaUnited States
In The Last Decade
Biwei Yang
49 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 101
- Cancer Research 299
- Hepatology 119
- Oncology 266
- Immunology 154
- Molecular Biology 453
Countries citing papers authored by Biwei Yang
This map shows the geographic impact of Biwei Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Biwei Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Biwei Yang more than expected).
Fields of papers citing papers by Biwei Yang
This network shows the impact of papers produced by Biwei Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Biwei Yang. The network helps show where Biwei Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Biwei Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 177 | |
| 2 | 2020 | 116 | |
| 3 | 2021 | 108 | |
| 4 | 2018 | 71 | |
| 5 | 2017 | 61 | |
| 6 | 2019 | 54 | |
| 7 | 2015 | 45 | |
| 8 | 2010 | 43 | |
| 9 | Surgical treatment of hepatocellular carcinoma and related basic research with special reference to recurrence and metastasis. | 1999 | 42 |
| 10 | 2011 | 36 | |
| 11 | 2023 | 33 | |
| 12 | 2021 | 32 | |
| 13 | 2018 | 30 | |
| 14 | 2021 | 29 | |
| 15 | 2018 | 26 | |
| 16 | 2014 | 23 | |
| 17 | 2021 | 22 | |
| 18 | 2015 | 19 | |
| 19 | 2019 | 17 | |
| 20 | 2021 | 17 |
About Biwei Yang
Biwei Yang is a scholar working on Molecular Biology, Oncology, Immunology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 50 papers that have together received 1.2k indexed citations. Recurring topics across this work include Immune cells in cancer (4 papers), Cancer Mechanisms and Therapy (4 papers), interferon and immune responses (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Cancer-related molecular mechanisms research (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers) and Proteoglycans and glycosaminoglycans research (2 papers). The work is most often cited by research in Cancer Research (299 citations), Hepatology (119 citations), Oncology (266 citations), Immunology (154 citations) and Molecular Biology (453 citations). Biwei Yang has collaborated with scholars based in China, Ethiopia and United States. Frequent co-authors include Jinglin Xia, Wenqing Tang, Si Zhang, Peixin Huang, Tingting Fang, Meiyi Li, Weixin Liu, Luonan Chen, Feifei Yuan and Zhiying Zhao. Their work appears in journals such as Journal of Translational Medicine, Experimental Cell Research, Journal of Experimental & Clinical Cancer Research, Cellular Physiology and Biochemistry and Journal of Ethnopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.